Comparison

TRON Network integrated with Token Terminal

Retrieved on: 
Wednesday, April 10, 2024

Zürich, Switzerland, March 12, 2024 - TRON DAO has collaborated with Token Terminal, integrating the TRON network’s data into Token Terminal’s sophisticated suite of data analytics tools.

Key Points: 
  • Zürich, Switzerland, March 12, 2024 - TRON DAO has collaborated with Token Terminal, integrating the TRON network’s data into Token Terminal’s sophisticated suite of data analytics tools.
  • Oskari Tempakka, Head of Growth at Token Terminal, commented on the increasing demand for TRON network data: “At Token Terminal, we've observed a growing interest towards TRON among our institutional clients.
  • The comprehensive data analytics provided by Token Terminal will enable a deeper understanding of TRON’s network and its strategic position in the blockchain industry.
  • In addition, Tronix (TRX), the native utility token of the TRON network, is eligible to be included in the MarketVector™ Token Terminal Fundamental Index Suite – a first-of-its-kind fundamentally-weighted basket of crypto assets that offers investors exposure to multi-token baskets, weighted based on economic traction.

Jamf Event showcases product innovations aimed at helping organizations meet security and compliance needs

Retrieved on: 
Tuesday, April 9, 2024

Compliance Editor with Jamf Pro for iOS and iPadOS removes ambiguity around enforcing compliance on mobile devices - Compliance Editor is the tool that generates deployable configuration files in Jamf Pro that allow organizations to meet CIS benchmarks.

Key Points: 
  • Compliance Editor with Jamf Pro for iOS and iPadOS removes ambiguity around enforcing compliance on mobile devices - Compliance Editor is the tool that generates deployable configuration files in Jamf Pro that allow organizations to meet CIS benchmarks.
  • Jamf announced Compliance Editor is now available for iOS and iPadOS, ensuring consistent security benchmarks can be met across Mac, iPhone and iPad.
  • Jamf Routines in Jamf Pro make powerful self-healing workflows a reality - Jamf announced Jamf Routines, which offers Jamf Pro customers new no-code automations and integrations to make IT teams more powerful and efficient.
  • With Jamf Routines, admins can also specify when a re-deploy of the Jamf Management Framework may be required to get devices back into compliance, improving overall security and compliance posture.

Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Monday, April 1, 2024

SEATTLE, April 01, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced financial results for the fourth quarter and full year ended December 31, 2023, and provided an update on recent Company developments.

Key Points: 
  • SEATTLE, April 01, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced financial results for the fourth quarter and full year ended December 31, 2023, and provided an update on recent Company developments.
  • Full enrollment was achieved in November 2023 and data is expected in the second half of 2024.
  • Factors contributing to the increased operating expenses in the year ended December 31, 2023 are explained below.
  • The following table provides a breakdown of major categories within R&D expense for the years ended December 31, 2023 and 2022, together with the dollar change in those categories (in thousands):

Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates

Retrieved on: 
Wednesday, March 27, 2024

CAPE CANAVERAL, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX ), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a corporate update.

Key Points: 
  • CAPE CANAVERAL, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX ), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a corporate update.
  • We also seek to advance UB-311, our anti-Aβ Alzheimer’s candidate, as we resume dialogue with regulatory authorities and partners.
  • General and administrative expenses were $3.4 million and $7.7 million for the three months ended December 31, 2023, and 2022, respectively.
  • General and administrative expenses were $22.4 million and $28.4 million for the years ended December 31, 2023, and 2022, respectively.

Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results

Retrieved on: 
Tuesday, March 26, 2024

SAN DIEGO, March 26, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today provided a corporate update and reported financial results for the fourth quarter and year ended December 31, 2023.

Key Points: 
  • Results demonstrated targeted drug delivery and absorption in the colon, with 3-4 times lower drug levels in blood
    SAN DIEGO, March 26, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today provided a corporate update and reported financial results for the fourth quarter and year ended December 31, 2023.
  • “We are thrilled by the results from the single ascending dose (SAD) portion of our clinical trial for BT-600.
  • During 2023, Biora reduced its outstanding notes by more than $80 million, resulting in a 75% reduction in net debt.
  • Comparison of Full-Year Ended December 31, 2023 and 2022
    Operating expenses were $67.1 million for the year ended December 31, 2023, compared to $62.1 million for the year ended December 31, 2022.

World Kitchen Furniture Market Outlook 2024, Featuring 35 Company Profiles Including American Woodmark, Boffi, Cabico, Hanssem, IKEA, Interwood, Nobia, Oppein, Scavolini, Schuller, Weizter and Zbom - ResearchAndMarkets.com

Retrieved on: 
Monday, April 8, 2024

World consumption of kitchen furniture is worth about USD 60 billion, accounting for about 15% of total world furniture consumption.

Key Points: 
  • World consumption of kitchen furniture is worth about USD 60 billion, accounting for about 15% of total world furniture consumption.
  • North America is the main consuming area, covering over one-third of the world's kitchen furniture market, followed by Europe and Asia Pacific.
  • Part 3: Company profiles provides company profiles for 35 among the main kitchen furniture manufacturers worldwide.
  • The 60 countries covered by the World Indicators of kitchen furniture were selected based on size of the economy, importance of the kitchen sector and contribution to world trade of kitchen furniture.

Agital Upgrades Its Agital Impact Platform, Introducing Sophisticated New Reporting and Analytics Capabilities

Retrieved on: 
Tuesday, March 19, 2024

Agital Impact offers a single view of performance across more than 25 channels and platforms and provides sophisticated capabilities to make future-proof decisions through forecasting and modeling.

Key Points: 
  • Agital Impact offers a single view of performance across more than 25 channels and platforms and provides sophisticated capabilities to make future-proof decisions through forecasting and modeling.
  • Agital Impact solves these challenges by going beyond performance tracking to deliver sophisticated modeling and holistic business insights.
  • Agital Impact offers out-of-the-box advanced analytics capabilities that help companies of all sizes - from SMBs to emerging enterprises and global brands - optimize business performance through accessible, easy-to-understand insights reporting.
  • Agital Impact also introduced Visualize, a cutting-edge application that integrates presentation capabilities into Agital Impact's sophisticated analytics suite, now comprising three different applications: Inform, Visualize, and Compare.

Aurion Biotech to Present Clinical Data at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Retrieved on: 
Tuesday, April 2, 2024

Aurion Biotech , whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced several presentations during the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting to be held April 5-8, 2024 in Boston, Massachusetts.

Key Points: 
  • Aurion Biotech , whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced several presentations during the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting to be held April 5-8, 2024 in Boston, Massachusetts.
  • “We are delighted to share additional insights into these clinical studies, in multiple sessions at the Eyecelerator and ASCRS 2024 meetings,” said Michael Goldstein, M.D., president and chief medical officer, Aurion Biotech.
  • The ABA-1 / CLARA trial is designed to assess the safety, tolerability, and efficacy of AURN001 for the treatment of corneal edema secondary to corneal endothelial dysfunction.
  • The primary endpoint is the percentage of subjects who gain 3 lines of vision at 6 months.

ServiceNow Named a Worldwide Leader in Two IDC MarketScapes for Value Stream Management and Strategic Portfolio Management

Retrieved on: 
Tuesday, March 19, 2024

ServiceNow (NYSE: NOW), the leading digital workflow company making the world work better for everyone, has been named a Leader in two IDC MarketScape vendor assessments:

Key Points: 
  • ServiceNow (NYSE: NOW), the leading digital workflow company making the world work better for everyone, has been named a Leader in two IDC MarketScape vendor assessments:
    According to the reports, “ServiceNow’s combined platform and execution across its Strategic Portfolio Management strategy enable a strong foundation for leverage for Project Portfolio Management, Application Portfolio Management, and Agile.
  • “Business leaders are looking to ServiceNow to deliver business outcomes and better adapt to change.
  • With the Now Platform, customers can leverage ServiceNow’s market-leading solutions for:
    Value Stream Management : Compare and manage teams to optimize workflows by connecting DevOps tools and teams to Service Portfolio Management.
  • Project Portfolio Management: Secure visibility across all work—traditional, agile, and hybrid—while balancing capacity against demand and optimizing portfolios to achieve business value.

DataRobot to Accelerate Enterprise-Ready AI Solutions with NVIDIA

Retrieved on: 
Monday, March 18, 2024

DataRobot, the leading AI platform at the forefront of value-driven AI innovation, today announced that its enterprise-ready AI solutions will be supercharged with NVIDIA technology to offer world-class performance, security and efficiency across the full AI lifecycle.

Key Points: 
  • DataRobot, the leading AI platform at the forefront of value-driven AI innovation, today announced that its enterprise-ready AI solutions will be supercharged with NVIDIA technology to offer world-class performance, security and efficiency across the full AI lifecycle.
  • “Combining DataRobot’s full AI lifecycle platform and NVIDIA’s accelerated AI computing software stack and unique optimization technology, this collaboration brings together cutting-edge capabilities to enable organizations to rapidly build, confidently operate and govern AI solutions at scale to drive transformative business impact.”
    This new collaboration with NVIDIA accelerates AI use case delivery.
  • Customers can now:
    Deploy fully-configured generative AI models with NVIDIA NIM microservices, included with NVIDIA AI Enterprise, which are designed to accelerate the deployment of generative AI across the cloud, data center and workstations.
  • Achieve peak performance, security and scalability with pre-built model container microservices in the DataRobot AI Platform , optimized for execution on top of NVIDIA devices.